PNV
POLYNOVO LIMITED ORDINARYPolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
PNV
PNV
POLYNOVO LIMITED ORDINARY
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn.
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 16 July | — | — |
| 15 July | — | — |
| 14 July | — | — |
| 13 July | 8.68% | — |
| 10 July | 8.62% | — |
| 9 July | 8.59% | — |
| 8 July | 8.62% | — |
| 7 July | 8.60% | — |
| 6 July | 8.54% | — |
| 3 July | 8.56% | — |
| 2 July | 8.64% | — |
| 1 July | 8.66% | — |
Polynovo Limited (PNV) Short Interest Summary
Polynovo Limited (PNV) currently has 8.68% of its shares sold short (60.0 million shares, worth approximately $61.8 million), based on ASIC short position data reported on 13 July 2026 (T+4 reporting lag). That makes PNV the #24 most shorted stock on the ASX most shorted list. Short interest in PNV is up 0.14% over the past week and up 0.52% over the past month. PNV is part of the Health Care sector on the ASX.
Recent PNV Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 13 July 2026 | 8.68% | 60.0M | $1.02 |
| 10 July 2026 | 8.62% | 59.6M | $1.01 |
| 9 July 2026 | 8.59% | 59.4M | $1.03 |
| 8 July 2026 | 8.62% | 59.6M | $1.00 |
| 7 July 2026 | 8.60% | 59.4M | $1.00 |
| 6 July 2026 | 8.54% | 59.0M | $1.00 |
| 3 July 2026 | 8.56% | 59.1M | $0.98 |
| 2 July 2026 | 8.64% | 59.7M | $0.95 |
| 1 July 2026 | 8.66% | 59.8M | $0.94 |
| 30 June 2026 | 8.59% | 59.3M | $0.92 |
PNV Short Selling — Frequently Asked Questions
What is Polynovo Limited (PNV)'s current short interest?
Polynovo Limited (PNV) currently has a short interest of 8.68% of total shares outstanding. This means 8.68% of PNV's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is PNV heavily shorted on the ASX?
PNV has a moderate level of short interest at 8.68%. While below the heavily shorted threshold of 10%, this indicates notable bearish positioning. PNV is currently ranked #24 among the most shorted stocks on the ASX.
What does short interest mean for PNV investors?
Short interest in PNV shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 8.68%, PNV's short interest is at a moderate level. See our short squeeze candidates and days to cover analysis for more context.
Where does this PNV short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for PNV.